Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCR1 | P32246 | 1/20 | 0.55 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.46 |
| ▸ | PGK1 | P00558 | 1/20 | 0.42 |
| ▸ | PGK2 | P07205 | 1/20 | 0.42 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
| ▸ | GRIN2D | O15399 | 2/20 | 0.39 |
| ▸ | GRIN3B | O60391 | 2/20 | 0.39 |
| ▸ | GRIN1 | Q05586 | 2/20 | 0.39 |
| ▸ | GRIN2A | Q12879 | 2/20 | 0.39 |
| ▸ | GRIN2B | Q13224 | 2/20 | 0.39 |
| ▸ | GRIN2C | Q14957 | 2/20 | 0.39 |
| ▸ | GRIN3A | Q8TCU5 | 2/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | CXCR4 | P61073 | 3/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | NOS1 | P29475 | 1/20 | 0.34 |
| ▸ | NOS2 | P35228 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Bromide SCHEMBL1259355 | 0.97 | CCR1 (0.52) | CCR1KCNH2PGK1PGK2HRH4 | |
| SCHEMBL18131277 | 0.87 | CCR1 (0.44) | CCR1KCNH2PGK1PGK2HRH4 | |
| SCHEMBL4046726 | 0.87 | KCNH2 (0.48) | CCR1KCNH2PGK1PGK2HRH4 | |
| SCHEMBL243652 | 0.87 | CCR1 (0.44) | CCR1KCNH2PGK1PGK2HRH4 | |
| SCHEMBL2840767 | 0.87 | CCR1 (0.44) | CCR1KCNH2PGK1PGK2HRH4 | |
| SCHEMBL3167663 | 0.86 | CCR1 (0.48) | CCR1KCNH2PGK1PGK2HRH4 | |
| SCHEMBL29561513 | 0.84 | — | — | |
| SCHEMBL506617 | 0.84 | — | — | |
| SCHEMBL9146011 | 0.84 | CCR1 (0.46) | CCR1KCNH2PGK1PGK2HRH4 | |
| SCHEMBL4045371 | 0.83 | KCNH2 (0.61) | CCR1KCNH2GRIN2DGRIN3BGRIN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 831 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120136929-A | Ruthenium-based catalyst, preparation method thereof and application of ruthenium-based catalyst in preparation of hydrogenated nitrile rubber in organic solvent | 山东链科新材料有限公司 | 2025-06-13 | — | — | CN | claimed |
| US-20250101475-A1 | MONOOXYGENASE MUTANTS FOR BIOSYNTHESIS OF 2,6-BIS(HYDROXYMETHYL)PYRIDINE AND A METHOD FOR PREPARATION OF 2,6-BIS(HYDROXYMETHYL)PYRIDINE USING THE SAID MONOOXYGENASE MUTANTS | VIO CHEMICALS AG (CH) | 2025-03-27 | — | — | US | claimed |
| CN-118871588-A | Monooxygenase mutants for biosynthesis of 2, 6-bis (hydroxymethyl) pyridine and method for preparing 2, 6-bis (hydroxymethyl) pyridine using same | VIO化学公司 | 2024-10-29 | — | — | CN | claimed |
| US-20240182526-A1 | COMPOSITIONS AND METHODS FOR MODULTING INFLAMMATORY AND DEGENERATIVE DISORDER | UNIV SOUTHERN CALIFORNIA (US) | 2024-06-06 | — | — | US | claimed |
| CN-117384159-A | Preparation method and application of long conjugated pyridinium macrocyclic photosensitizer | 暨南大学 | 2024-01-12 | — | — | CN | claimed |
| CN-113683645-B | Binuclear Pt (II) complex with anti-tumor activity and preparation method and application thereof | 湖北科技学院 | 2023-11-07 | — | — | CN | claimed |
| CN-115246797-B | Azacrown ether compound, and preparation method and application thereof | 中国科学院上海高等研究院 | 2023-07-21 | — | — | CN | claimed |
| WO-2023126510-A1 | MONOOXYGENASE MUTANTS FOR BIOSYNTHESIS OF 2,6-BIS(HYDROXYMETHYL)PYRIDINE AND A METHOD FOR PREPARATION OF 2,6-BIS(HYDROXYMETHYL)PYRIDINE USING THE SAID MONOOXYGENASE MUTANTS | VIO CHEMICALS AG (CH) | 2023-07-06 | — | — | WO | claimed |
| CN-115246797-A | Aza-crown ether compound and preparation method and application thereof | 中国科学院上海高等研究院 | 2022-10-28 | — | — | CN | claimed |
| WO-2022212513-A1 | COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATORY AND DEGENERATIVE DISORDER | UNIVERSITY OF SOUTHERN CALIFORNIA (US) | 2022-10-06 | — | — | WO | claimed |
| US-20160083430-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | RA PHARMACEUTICALS, INC. | 2016-03-24 | — | — | US | claimed |
| US-9238676-B2 | Peptide and peptidomimetic inhibitors | RA PHARMACEUTICALS, INC. (US) | 2016-01-19 | — | — | US | claimed |
| WO-2015191951-A2 | MODULATION OF COMPLEMENT ACTIVITY | RA PHARMACEUTICALS, INC. (US) | 2015-12-17 | — | — | WO | claimed |
| US-20150166606-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | RA PHARMACEUTICALS, INC. | 2015-06-18 | — | — | US | claimed |
| EP-2850095-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | RA Pharmaceuticals, Inc. (US) | 2015-03-25 | — | — | EP | claimed |
| EP-2216372-B1 | Compounds for preventing Ghost odour | THOR GMBH (DE) | 2014-06-04 | — | — | EP | claimed |
| WO-2013172954-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | RA PHARMACEUTICALS, INC (US) | 2013-11-21 | — | — | WO | claimed |
| US-7618913-B2 | Coordination catalyst containing an organosilicon compound , nitrogen compound, transition metal compound and magnesiumon compound on catalyst support | FORMOSA PLASTICS CORPORATION, U.S.A. (US) | 2009-11-17 | — | — | US | claimed |
| WO-2008027479-A2 | HIGHLY ACTIVE ALPHA-OLEFIN COPOLYMERIZATION CATALYST SYSTEM | FORMOSA PLASTICS CORPORATION, U.S.A. (US) | 2008-03-06 | — | — | WO | claimed |
| US-20080058198-A1 | Highly active alpha-olefin copolymerization catalyst system | FORMOSA PLASTICS CORPORATION, U.S.A. | 2008-03-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150166606-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | KLKB1, KLK1, KLK5 | CCR1 905/4885KCNH2 2254/4885PGK1 979/4885 |
| US-20160083430-A1 | PEPTIDE AND PEPTIDOMIMETIC INHIBITORS | KLKB1, KLK1, KLK5 | CCR1 905/4885KCNH2 2254/4885PGK1 979/4885 |
| US-20240182526-A1 | COMPOSITIONS AND METHODS FOR MODULTING INFLAMMATORY AND DEGENERATIVE DISORDER | TNF, AGER, GRN | CCR1 1585/4885KCNH2 4086/4885PGK1 2782/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.